Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

dc.contributor.author

Cho, Alex H

dc.contributor.author

Killeya-Jones, Ley A

dc.contributor.author

O'Daniel, Julianne M

dc.contributor.author

Kawamoto, Kensaku

dc.contributor.author

Gallagher, Patrick

dc.contributor.author

Haga, Susanne

dc.contributor.author

Lucas, Joseph E

dc.contributor.author

Trujillo, Gloria M

dc.contributor.author

Joy, Scott V

dc.contributor.author

Ginsburg, Geoffrey S

dc.coverage.spatial

England

dc.date.accessioned

2017-02-01T14:31:59Z

dc.date.issued

2012-01-18

dc.description.abstract

BACKGROUND: Type 2 diabetes is a prevalent chronic condition globally that results in extensive morbidity, decreased quality of life, and increased health services utilization. Lifestyle changes can prevent the development of diabetes, but require patient engagement. Genetic risk testing might represent a new tool to increase patients' motivation for lifestyle changes. Here we describe the rationale, development, and design of a randomized controlled trial (RCT) assessing the clinical and personal utility of incorporating type 2 diabetes genetic risk testing into comprehensive diabetes risk assessments performed in a primary care setting. METHODS/DESIGN: Patients are recruited in the laboratory waiting areas of two primary care clinics and enrolled into one of three study arms. Those interested in genetic risk testing are randomized to receive either a standard risk assessment (SRA) for type 2 diabetes incorporating conventional risk factors plus upfront disclosure of the results of genetic risk testing ("SRA+G" arm), or the SRA alone ("SRA" arm). Participants not interested in genetic risk testing will not receive the test, but will receive SRA (forming a third, "no-test" arm). Risk counseling is provided by clinic staff (not study staff external to the clinic). Fasting plasma glucose, insulin levels, body mass index (BMI), and waist circumference are measured at baseline and 12 months, as are patients' self-reported behavioral and emotional responses to diabetes risk information. Primary outcomes are changes in insulin resistance and BMI after 12 months; secondary outcomes include changes in diet patterns, physical activity, waist circumference, and perceived risk of developing diabetes. DISCUSSION: The utility, feasibility, and efficacy of providing patients with genetic risk information for common chronic diseases in primary care remain unknown. The study described here will help to establish whether providing type 2 diabetes genetic risk information in a primary care setting can help improve patients' clinical outcomes, risk perceptions, and/or their engagement in healthy behavior change. In addition, study design features such as the use of existing clinic personnel for risk counseling could inform the future development and implementation of care models for the use of individual genetic risk information in primary care. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00849563.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/22257365

dc.identifier

1472-6963-12-16

dc.identifier.eissn

1472-6963

dc.identifier.uri

https://hdl.handle.net/10161/13545

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

BMC Health Serv Res

dc.relation.isversionof

10.1186/1472-6963-12-16

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Aged

dc.subject

Aged, 80 and over

dc.subject

Attitude to Health

dc.subject

Diabetes Mellitus, Type 2

dc.subject

Genetic Predisposition to Disease

dc.subject

Genetic Testing

dc.subject

Health Behavior

dc.subject

Humans

dc.subject

Middle Aged

dc.subject

Outcome Assessment (Health Care)

dc.subject

Patient Education as Topic

dc.subject

Primary Health Care

dc.subject

Prospective Studies

dc.subject

Research Design

dc.subject

Risk Assessment

dc.subject

Risk Factors

dc.subject

Young Adult

dc.title

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

dc.type

Journal article

duke.contributor.orcid

Haga, Susanne|0000-0001-8817-7406

duke.contributor.orcid

Ginsburg, Geoffrey S|0000-0003-4739-9808

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/22257365

pubs.begin-page

16

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Biomedical Engineering

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Community and Family Medicine

pubs.organisational-group

Community and Family Medicine, Family Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Science & Society

pubs.organisational-group

Global Health Institute

pubs.organisational-group

Initiatives

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Cardiology

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Pratt School of Engineering

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

Sanford School of Public Policy - Secondary Group

pubs.organisational-group

School of Medicine

pubs.organisational-group

School of Nursing

pubs.organisational-group

School of Nursing - Secondary Group

pubs.organisational-group

Social Science Research Institute

pubs.organisational-group

University Institutes and Centers

pubs.publication-status

Published online

pubs.volume

12

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.pdf
Size:
2.25 MB
Format:
Adobe Portable Document Format